MYDA Advisors’s LifeMD LFMD Stock Holding History

MYDA Advisors’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-150,000	Closed	-$512K	–	185
2025 Q4	$512K	Buy	+150,000	New	+$728K	0.1%	116
2023 Q4	–	Sell	-60,000	Closed	-$375K	–	109
2023 Q3	$375K	Buy	+60,000	New	+$260K	0.12%	82

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MYDA Advisors's LFMD Position: Q1 2026 in Review

MYDA Advisors sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 150,000 shares — an estimated $512K sold.

MYDA Advisors first reported a position in LFMD in Q3 2023 and held it in 2 quarters. The position peaked at $512K in Q4 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

MYDA Advisors reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
MYDA Advisors sold 150,000 LifeMD shares in Q1 2026, an estimated $512K.
MYDA Advisors first reported a position in LifeMD in Q3 2023 and held it in 2 quarters.
MYDA Advisors's LifeMD position peaked at $512K in Q4 2025.
102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on MYDA Advisors's 13F filing for Q1 2026, filed 14 May 2026.